Clarus Wealth Advisors Sangamo Therapeutics, Inc Transaction History

Clarus Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$9.05 - $12.22 $9,050 - $12,220	-1,000 Closed	0 $0
Q4 2018 Jan 08, 2019	BUY	$9.51 - $16.6 $9,510 - $16,600	1,000 New	1,000 $17,000
Q4 2018 Jan 07, 2019	SELL	$9.51 - $16.6 $9,510 - $16,600	-1,000 Closed	0 $0
Q2 2018 Jul 05, 2018	BUY	$13.9 - $19.8 $13,900 - $19,800	1,000 New	1,000 $19,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $177M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.